{"entity":{"id":"5fb834b3-52b0-5461-abf5-7870250dcd42","name":"Aberdeen Pharmaceuticals, Ltd.","type":"Organization","kind":"company","jurisdiction":null,"identifier":"icij:icijol-80007469","risk":"LOW","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"shareholder of","share":null,"asset":{"id":"c4958aa7-2185-5e04-a2c6-d2052c9a22df","name":"Aberdeen Supply, Ltd.","type":"Company","kind":"company"}},{"role":"shareholder of","share":null,"asset":{"id":"968fe219-848e-5f91-a58b-747c93a71f1b","name":"Aberdeen Holdings, Ltd.","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"icij_offshoreleaks","source_url":"https://offshoreleaks.icij.org/nodes/80007469"}],"source":"corpus"}